Synthetic 2-Methoxyestradiol Derivatives: Structure-Activity Relationships
Authors: Peyrat, Jean-Francois; Brion, Jean-Daniel; Alami, Mouad
Source: Current Medicinal Chemistry, Volume 19, Number 24, August 2012 , pp. 4142-4156(15)
Publisher: Bentham Science Publishers
Abstract:— 2-Methoxyestradiol (2ME2), a natural metabolite of estradiol which has no estrogenic activity, is a potent antitumor and anti-angiogenic compound, currently undergoing clinical trials for treatment of a variety of cancers. In the last two decades, an ever increasing number of synthetic 2-methoxyestradiol analogues have been reported. Structural changes include A/B/C/D-rings modification, homologation, aromatization, and introduction of various substituents on C-2 position along with substitution of alkyl and ethynyl groups for the 17-hydroxy function. In this review, an attempt has been made to compile the structure-activity relationships of various synthesized 2-methoxyestradiol analogues.
Keywords: antiangiogenesis; anticancer agents; antimitotic activity; antiproliferative activity; apoptotic activity; structure-activity relationships; ï»¿aromatization; ï»¿ethynyl groups; ï»¿homologation; — 2-Methoxyestradiol
Document Type: Research Article
Publication date: 2012-08-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.